Age-related macular degeneration (AMD) is a leading cause of irreversible legal blindness worldwide. Treatments exist for late-stage AMD, but none exists for the intermediate stage (iAMD), which precedes significant vision loss. A therapy tested in iAMD would aim to prevent or slow progression to late-stage disease, me...
Alessandro Berni, P. Rosenfeld, D. Bacherini et al.· Progress in retinal and eye...· 0 citations
Current evidence on the definition, epidemiology, risk factors, imaging features, and functional consequences of MA in nAMD are summarized and standardized definitions, multimodal imaging, and predictive models are guided to guide personalized management and develop therapies targeting atrophy.
Xue-Nan Zhuang, Chiara Olivieri, G. Neri et al.· Survey of ophthalmology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.